Found 10 matching trials
Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC PHASE2 Study to determine the effect of the investigational drug bezafibrate (BZF)...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study PHASE2 We propose to test the hypothesis that bezafibrate, a pan-PPAR agonist, may...
Show More Location
The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital
Learn More & Join Trial
Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis PHASE3 Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease that...
Show More Location
Hepatology department - Hopital Saint Antoine
Learn More & Join Trial
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate PHASE3 An Open Label Long-Term Study to Evaluate the Safety and Tolerability of th...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic Strategies NA The investigators aim to examine the impact of changes in plasma lipoprotei...
Show More Location
Azienda Ospedaliero-Universitaria Pisana
Learn More & Join Trial
Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy PHASE3 Primary biliary cholangitis (PBC) is a rare chronic, progressive, cholestat...
Show More Location
Hepatology department - Hospital Saint Antoine
Learn More & Join Trial
The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD) NA X-linked adrenoleukodystrophy (X-ALD) is an inherited metabolic disorder ch...
Show More Location
Academisch Medisch Centrum
Learn More & Join Trial
Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction PHASE4 Introduction: Plasma fibrinogen levels have been identified as an important...
Show More Location
Multiple Locations
Learn More & Join Trial
Bezafibrate Plus Berberine in Mixed Dyslipidemia PHASE3 Dyslipidemia, is a cardiovascular risk factor of great importance whose pre...
Show More Location
Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara
Learn More & Join Trial
Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC PHASE2 Study to evaluate the efficacy, safety, and tolerability of investigational...
Show More Location
Flinders Medical Centre
Learn More & Join Trial